María Pilar López García-rekin lankidetzan egindako argitalpenak (6)

2023

  1. Effects of elevated emotional symptoms on metabolic disease development: a 10-year follow-up study

    Frontiers in Psychiatry, Vol. 14

  2. Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 121

2022

  1. Relationship between immunometabolic status and cognitive performance among major depression disorder patients

    Psychoneuroendocrinology, Vol. 137

2021

  1. Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder

    Journal of Affective Disorders, Vol. 279, pp. 343-352

  2. Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder

    Neuroscience Letters, Vol. 765

2019

  1. Inflammatory and metabolic disturbances are associated with more severe trajectories of late-life depression

    Psychoneuroendocrinology, Vol. 110